Controversy over Effects of Tamiflu Continues

Controversy over Effects of Tamiflu Continues

In a recent report, the department of health has made it clear that patients having fragile immune system must take Tamiflu. Though there are questions raised over the positive effects of the antiviral drug, there are reports recommending the drug for time being.

It has been told that there were glaring reports in the British Medical Journal (BMJ) about the drug reducing the life of patients, though no tangible evidence could be find out. Even a team from the Cochrane Collaboration has peeped into 20 studies concerning the same issue, and claimed that the drug could not reduce the risk related with influenza-related lower respiratory tract complications. As of now, there are no clear cut reports being released for people to follow.

Even pharmaceutical giant Roche is being lashed out for not conducting the study with complete evidence, which has been completely denied by the company. It was told that despite incessant requests to the company, no extended support was given to the current investigators. However, Roche is of the say that they have provided all the available details of the study in the peer-reviewed publications or in summary form on www. roche-trials. com.

Despite the controversy, the UK government is accepting contracts for 50 million doses of Tamiflu. "We cannot be certain whether the trial evidence supports the conclusion that (Tamiflu) reduces complications”, the report said. “Nor do we understand if and how (Tamiflu) changes immune response, and important questions about its mode of action remain”.

It is required that rational decisions are being made after taking into account all possible angles of the underlying theory. Even Dr. Fiona Godlee, Editor-In-Chief of the BMJ has asserted that it would take some more time to actually reach to the conclusion about the drug.

As of now, patients are being given the same drug to beat the risk of flu, but final report concerning the same is awaited.


FrenchTribune Specials

U.S. Surgeon General Calls for Immediate Action to Reduce Skin Cancer Cases

On Tuesday, a report has been released in which America's Surgeon General has asked for quick steps to reduce the rate of skin cancer. It is the most common skin cancer in the US and also the one that can be prevented.

U. S. Surgeon General Rear Adm. Boris Lushniak said that Americans are making efforts, but they are not sufficient. They...

Most Popular

HTC to Launch Windows Phone with 1280*800 Resolution Support

After launching HTC 8S and HTC 8X in 2012, Taiwanese...

Astronauts Preparing for Asteroid Mission in Underwater Lab

Four US astronauts have been reportedly living 19 meters...

Web cam Captures Loggerhead Sea Turtles’ Hatchings

On Friday, hatchings of hundreds of tiny loggerhead sea...

Poll

Can Greece Come out of Economic Problems: